Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine

Oragenics is a development-stage biotechnology company focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI), also known as concussion, and for treating Niemann Pick Disease Type C (NPC), as well as proprietary powder formulation and an intranasal delivery device. For more information, please visit www.oragenics.com. Webinar Topic: Neurotrauma Medicine When: Monday, May 20, 2024 Time: 1 ...